Lance G. Hammerland

1.9k total citations
16 papers, 1.5k citations indexed

About

Lance G. Hammerland is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Nephrology. According to data from OpenAlex, Lance G. Hammerland has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 2 papers in Nephrology. Recurrent topics in Lance G. Hammerland's work include Ion channel regulation and function (7 papers), Neuroscience and Neuropharmacology Research (7 papers) and Chemical Synthesis and Analysis (3 papers). Lance G. Hammerland is often cited by papers focused on Ion channel regulation and function (7 papers), Neuroscience and Neuropharmacology Research (7 papers) and Chemical Synthesis and Analysis (3 papers). Lance G. Hammerland collaborates with scholars based in United States, Sweden and Australia. Lance G. Hammerland's co-authors include Edward F. Nemeth, James E. Garrett, Bradford C. Van Wagenen, Manuel F. Balandrin, Eric G. DelMar, Michael E. Steffey, Forrest Fuller, Edward M. Brown, Steven Hébert and Michael C. Sanguinetti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and FEBS Letters.

In The Last Decade

Lance G. Hammerland

16 papers receiving 1.4k citations

Peers

Countries citing papers authored by Lance G. Hammerland

Since Specialization

Citations

This map shows the geographic impact of Lance G. Hammerland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lance G. Hammerland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lance G. Hammerland more than expected).

Fields of papers citing papers by Lance G. Hammerland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lance G. Hammerland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lance G. Hammerland. The network helps show where Lance G. Hammerland may publish in the future.

Co-authorship network of co-authors of Lance G. Hammerland

This figure shows the co-authorship network connecting the top 25 collaborators of Lance G. Hammerland. A scholar is included among the top collaborators of Lance G. Hammerland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lance G. Hammerland. Lance G. Hammerland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Parasite neuropeptide biology: Seeding rational drug target selection? 2011 ·International Journal for Parasitology Drugs and Drug Resistance ·Paul McVeigh, Louise E. Atkinson, Nikki J. Marks, Angela Mousley, Johnathan J. Dalzell, Ann E. Sluder, Lance G. Hammerland, Aaron G. Maule	42
2	Modulation of Group III Metabotropic Glutamate Receptors by Hydrogen Ions 2008 ·Pharmacology ·(unknown), (unknown), (unknown), Laura Storjohann, Bradford C. Van Wagenen, (unknown), Lance G. Hammerland	10
3	Structure–activity relationship of thiopyrimidines as mGluR5 antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Lance G. Hammerland, Martin Johansson, Jonas Malmström, Jan P. Mattsson, Alexander B. E. Minidis, Karolina Nilsson, (unknown), David Wensbo, Andreas Wållberg, (unknown)	12
4	Structure–activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5) 2006 ·Bioorganic & Medicinal Chemistry Letters ·Peter Bach, Karolina Nilsson, (unknown), Udo Bauer, Lance G. Hammerland, (unknown), Andreas Wållberg, (unknown), (unknown), (unknown), David Wensbo	19
5	A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5) 2006 ·Bioorganic & Medicinal Chemistry Letters ·Peter Bach, Karolina Nilsson, Andreas Wållberg, Udo Bauer, Lance G. Hammerland, (unknown), (unknown), (unknown), (unknown), (unknown), David Wensbo	24
6	Phenyl ureas of creatinine as mGluR5 antagonists. A structure–activity relationship study of fenobam analogues 2005 ·Bioorganic & Medicinal Chemistry Letters ·Andreas Wållberg, Karolina Nilsson, (unknown), (unknown), Susanne Elg, Patrick Raboisson, Udo Bauer, Lance G. Hammerland, Jan P. Mattsson	14
7	Recent Advances in Non-Competitive mGlu5 Receptor Antagonists and their Potential Therapeutic Applications 2005 ·Current Topics in Medicinal Chemistry ·Abdelmalik Slassi, Methvin Isaac, Louise Edwards, Alexander B. E. Minidis, David Wensbo, Jan P. Mattsson, Karolina Nilsson, Patrick Raboisson, Donald A. McLeod, (unknown), Lance G. Hammerland, Edwin C. Johnson	42
8	Domains Determining Ligand Specificity for Ca2+ Receptors 1999 ·Molecular Pharmacology ·Lance G. Hammerland, K. Krapcho, James E. Garrett, (unknown), (unknown), Rachel T. Simin, Cyrus Levinthal, E.F. Nemeth, Forrest Fuller	93
9	Allosteric Activation of the Ca2+ Receptor Expressed in Xenopus laevis Oocytes by NPS 467 or NPS 568 1998 ·Molecular Pharmacology ·Lance G. Hammerland, James E. Garrett, (unknown), (unknown), Edward F. Nemeth	102
10	Calcimimetics with potent and selective activity on the parathyroid calcium receptor 1998 ·Proceedings of the National Academy of Sciences ·Edward F. Nemeth, Michael E. Steffey, Lance G. Hammerland, (unknown), Bradford C. Van Wagenen, Eric G. DelMar, Manuel F. Balandrin	485
11	Heteropodatoxins: Peptides Isolated from Spider Venom that Block Kv4.2 Potassium Channels 1997 ·Molecular Pharmacology ·Michael C. Sanguinetti, JANICE H. JOHNSON, Lance G. Hammerland, Paul R. Kelbaugh, Robert A. Volkmann, Nicholas A. Saccomano, Alan L. Mueller	149
12	Molecular Cloning and Functional Expression of Human Parathyroid Calcium Receptor cDNAs 1995 ·Journal of Biological Chemistry ·James E. Garrett, (unknown), Lance G. Hammerland, (unknown), Edward M. Brown, Steven Hébert, Edward F. Nemeth, Forrest Fuller	406
13	Voltage-activated potassium currents of rabbit osteoclasts: effects of extracellular calcium 1994 ·American Journal of Physiology-Cell Physiology ·Lance G. Hammerland, Arpana Parihar, Edward F. Nemeth, Michael C. Sanguinetti	13
14	Functional expression of the parathyroid cell calcium receptor in Xenopus oocytes 1993 ·FEBS Letters ·Frederick Racke, Lance G. Hammerland, George Dubyak, Edward F. Nemeth	25
15	γ-d-glutamylaminomethyl sulfonic acid (GAMS) distinguishes kainic acid- from AMPA-induced responses in Xenopus oocytes expressing chick brain glutamate receptors 1993 ·Neuropharmacology ·Nan Zhou, Lance G. Hammerland, Thomas N. Parks	20
16	Conantokin-G selectively inhibits N-methyl-D-aspartate-induced currents in Xenopus oocytes injected with mouse brain mRNA 1992 ·European Journal of Pharmacology Molecular Pharmacology ·Lance G. Hammerland, (unknown), Doju Yoshikami	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact